Mark L. Day

8.8k citations
117 papers · 6.6k · h-index 45

Impact in

Papers in

    • Cancer-related gene regulation 12
    • Wnt/β-catenin signaling in development and cancer 10
    • Epigenetics and DNA Methylation 9
    • HER2/EGFR in Cancer Research 10
    • Cancer-related Molecular Pathways 9

Mark L. Day

114 papers receiving 6.5k citations

Peers

Mark L. Day
Comparison fields: 5 of 142
  • Behavioral Neuroscience 407
  • Cellular and Molecular Neuroscience 1.3k
  • Developmental Neuroscience 229
  • Immunology and Allergy 308
  • Biological Psychiatry 119
Replace Nigel Whittle with:
Nigel Whittle Austria
Paul C. Orban Canada
Keiko Mizuno Japan
Theodore J. Brown Canada
Mark G. Erlander United States
Markku Pelto‐Huikko Finland
Jian Feng United States
Sarah E. Ross United States
Oliver Kretz Germany
John E. Pintar United States
Mark L. Day relative to Nigel Whittle Austria Nigel Whittle's profile →
Citations per field
00.5×1.7×
Nigel Whittle · 1×
Citations per year

Countries citing papers authored by Mark L. Day

Since Specialization
Citations

This map shows the geographic impact of Mark L. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Day more than expected).

Fields of papers citing papers by Mark L. Day

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Day. The network helps show where Mark L. Day may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark L. Day, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark L. Day Line = papers co-authored together Mark L. Day links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.
1995452
2 2008410
3 2003386
4
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
1995273
5 2003203
6 2008203
7 2008154
8 2008153
9 2007149
10 2003148
11 2016145
12 2001143
13 2005136
14 1999128
15 1987126
16 2006113
17 1997101
18 1999100
19 200697
20 198794

About Mark L. Day

Mark L. Day is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Pulmonary and Respiratory Medicine and Surgery, having authored 117 papers that have together received 6.6k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (17 papers), Prostate Cancer Treatment and Research (12 papers), Cancer-related gene regulation (12 papers), Bladder and Urothelial Cancer Treatments (12 papers), HER2/EGFR in Cancer Research (10 papers), Wnt/β-catenin signaling in development and cancer (10 papers), Epigenetics and DNA Methylation (9 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Behavioral Neuroscience (407 citations), Cellular and Molecular Neuroscience (1.3k citations), Developmental Neuroscience (229 citations), Immunology and Allergy (308 citations) and Biological Psychiatry (119 citations). Mark L. Day has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Kathleen C. Day, Michael T. McCabe, Richard Morris, Mark A. Rubin, Abdo J. Najy, Rainer Kuefer, Anthony J. Raffo, Harris Perlman, Ralph Buttyan and Min‐Wei Chen. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Oncogene, Journal of Pharmacology and Experimental Therapeutics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact